BE844203A - Nouvelle composition pharmaceutique pour l'administration parenterale,agissant sur le systheme nerveux central - Google Patents

Nouvelle composition pharmaceutique pour l'administration parenterale,agissant sur le systheme nerveux central

Info

Publication number
BE844203A
BE844203A BE168963A BE168963A BE844203A BE 844203 A BE844203 A BE 844203A BE 168963 A BE168963 A BE 168963A BE 168963 A BE168963 A BE 168963A BE 844203 A BE844203 A BE 844203A
Authority
BE
Belgium
Prior art keywords
acting
pharmaceutical composition
nervous system
central nervous
parenteral administration
Prior art date
Application number
BE168963A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE844203A publication Critical patent/BE844203A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE168963A 1975-07-16 1976-07-16 Nouvelle composition pharmaceutique pour l'administration parenterale,agissant sur le systheme nerveux central BE844203A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (1)

Publication Number Publication Date
BE844203A true BE844203A (fr) 1977-01-17

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
BE168963A BE844203A (fr) 1975-07-16 1976-07-16 Nouvelle composition pharmaceutique pour l'administration parenterale,agissant sur le systheme nerveux central

Country Status (11)

Country Link
US (1) US4016273A (https=)
BE (1) BE844203A (https=)
CA (1) CA1062159A (https=)
DE (1) DE2630394A1 (https=)
DK (1) DK319776A (https=)
FI (1) FI762053A7 (https=)
FR (1) FR2317912A1 (https=)
GB (1) GB1525425A (https=)
NL (1) NL7607918A (https=)
PT (1) PT65358B (https=)
SE (1) SE7608114L (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
JP4361710B2 (ja) * 2000-04-19 2009-11-11 ジェネンテック・インコーポレーテッド 徐放製剤
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
AU2002320122B2 (en) * 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
BRPI0418304A (pt) * 2004-01-07 2007-05-02 Trimeris Inc peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv
PL1838716T3 (pl) * 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
US7456251B2 (en) * 2006-02-02 2008-11-25 Trimeris, Inc. HIV fusion inhibitor peptides with improved biological properties
ES2346005T3 (es) * 2006-07-27 2010-10-07 Cognis Ip Management Gmbh Procedimiento para la obtencion de glicerina.
BRPI0809995A2 (pt) * 2007-04-03 2015-07-21 Trimeris Inc Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
KR20100080812A (ko) * 2007-09-25 2010-07-12 트라이머리스, 인코퍼레이티드 치료용 항-ｈｉｖ 펩티드의 합성 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Also Published As

Publication number Publication date
PT65358B (en) 1978-01-09
DE2630394A1 (de) 1977-02-03
PT65358A (en) 1976-08-01
SE7608114L (sv) 1977-01-17
NL7607918A (nl) 1977-01-18
US4016273A (en) 1977-04-05
FR2317912B1 (https=) 1979-04-13
CA1062159A (en) 1979-09-11
DK319776A (da) 1977-01-17
FI762053A7 (https=) 1977-01-17
FR2317912A1 (fr) 1977-02-11
GB1525425A (en) 1978-09-20

Similar Documents

Publication Publication Date Title
BE849632A (fr) Composition pharmaceutique pour l'administration orale
BE847283A (fr) Nouveaux medicaments derives de l'indole,
BE844203A (fr) Nouvelle composition pharmaceutique pour l'administration parenterale,agissant sur le systheme nerveux central
FR2321655A1 (fr) Moderateur de debit, notamment pour dispositifs d'injection intraveineuse
FR2333521A1 (fr) Dispositif d'administration d'un liquide par voie parenterale
RO69608A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazol-3-one
BE838823A (fr) Procede pour la preparation de 1,2,5-dihydroxycholecalciferol
HU171823B (hu) Sposob poluchenija vspomogatel'nogo materiala dlja obrabotki polivinilkhlorida, modificirovannogo s poliakrilatom
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
BE762232A (fr) Procede pour la preparation d'anilines n,n-dihaloalkyl-2,6- dinitro-4-substituees
CH551200A (fr) Composition pour l'enrobage des medicaments.
PH13669A (en) 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
BE805912A (fr) Structure d'electrode pour installation d'electroclimatisation
RO76667A (ro) Procedeu pentru prepararea unor 2,4-dialchilamino-6-clor-5-triazine
BE842830A (fr) Douille d'arret pour broches de teinturerie
BR7409983A (pt) Processo aperfeicoado para a preparacao de n,n,n',n'-tetrafenildiamino-metano
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
FR2318166A1 (fr) Procede de preparation continue de 2,5-dioxo-1-oxa-2-phospholanes
BE845017A (fr) Procede pour l'obtention d'alpha,alpha,alpha,alpha',alpha',-pentachloro-o-xylene
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.
CA1035359A (en) 1-substituted-6,7-disubstituted-1,2,3,4-tetrahydroisoquinoline derivatives
PH10997A (en) 4-h-benzo(4,5)cyclochepta-(1,2-b)thiophen derivatives and pharmaceutical composition thereof
SU565688A1 (ru) Устройство дл очистки жидкости от твердых включений
RO70236A (ro) Procedeu pentru prepararea unor 1,2,4-oxadiazolidin-3-one